PharmacofMRI [functional magnetic resonance imaging] of Anxiolytic Medications (Pregabalin).
Phase of Trial: Phase IV
Latest Information Update: 29 Dec 2011
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacodynamics
- 01 Jun 2011 Results published in Neuropsychopharmacology.
- 20 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2008 New trial record.